Copyright © 2006, European Society of Cardiology
Integrin signalling: The tug-of-war in heart hypertrophy
aDepartment of Genetics, Biology, and Biochemistry, Turin University, Via Santena, 5bis, 10126 Turin, Italy
bDepartment of Angiocardioneurology, I.R.C.C.S. "Neuromed", 86077 Pozzilli (IS), Italy
cExperimental Medicine Research Center, San Giovanni Battista Hospital, 10126 Turin, Italy
dDepartment of Experimental Medicine and Pathology, "La Sapienza" University of Rome, Italy
* Corresponding author. Department of Genetics, Biology, and Biochemistry, Turin University, Via Santena, 5bis, 10126 Turin, Italy. Tel.: +39 011 6705858; fax: +39 011 6705853. Email address: guido.tarone{at}unito.it
The mechanical stress imposed by hemodynamic overload on heart walls is a primary event in triggering the cardiac hypertrophic response. Integrins, a class of membrane receptors, are major players in transmitting the mechanical force across the plasma membrane and sensing the mechanical load in cardiomyocytes. In fact, integrins, together with a number of associated cytoskeletal proteins, connect the sarcomeric contractile apparatus to the extracellular matrix across the plasma membrane and trigger intracellular signaling pathways activating the cardiomyocyte hypertrophy program.
In this review, we will discuss the role of the muscle-specific integrin isoform β1D and of associated proteins such as FAK, melusin, vinculin, zyxin, VASP, and migfilin that are the most upstream elements ("initiators") activated by mechanical strain. These molecules trigger a coordinated downstream signaling cascade involving proteins such as AKT, RAS, and MAPKs that execute the biochemical program leading to cardiomyocyte hypertrophy. Better understanding of the functional role of the initiator elements is of key importance to developing novel strategies to control cardiac hypertrophy and prevent heart failure.
KEYWORDS Cardiac hypertrophy; Integrins; Mechano-transduction; Signal transduction
Time for primary review 34 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. L. Sartoretto, B. Y. Jin, M. Bauer, F. B. Gertler, R. Liao, and T. Michel Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1697 - H1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. DiMichele, Z. S. Hakim, R. L. Sayers, M. Rojas, R. J. Schwartz, C. P. Mack, and J. M. Taylor Transient Expression of FRNK Reveals Stage-Specific Requirement for Focal Adhesion Kinase Activity in Cardiac Growth Circ. Res., May 22, 2009; 104(10): 1201 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bupha-Intr, K. M. Haizlip, and P. M. L. Janssen Temporal changes in expression of connexin 43 after load-induced hypertrophy in vitro Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H806 - H814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Linke Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction Cardiovasc Res, March 1, 2008; 77(4): 637 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Dowling, E. Gibbs, M. Russell, D. Goldman, J. Minarcik, J. A. Golden, and E. L. Feldman Kindlin-2 Is an Essential Component of Intercalated Discs and Is Required for Vertebrate Cardiac Structure and Function Circ. Res., February 29, 2008; 102(4): 423 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oka, J. Xu, R. A. Kaiser, J. Melendez, M. Hambleton, M. A. Sargent, A. Lorts, E. W. Brunskill, G. W. Dorn II, S. J. Conway, et al. Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling Circ. Res., August 3, 2007; 101(3): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Thamilselvan, D. H. Craig, and M. D. Basson FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway FASEB J, June 1, 2007; 21(8): 1730 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Hannigan, J. G. Coles, and S. Dedhar Integrin-Linked Kinase at the Heart of Cardiac Contractility, Repair, and Disease Circ. Res., May 25, 2007; 100(10): 1408 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Hall, E. J. Birks, S. Grindle, M. E. Cullen, P. J. Barton, J. E. Rider, S. Lee, S. Harwalker, A. Mariash, N. Adhikari, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy Eur. Heart J., March 1, 2007; 28(5): 613 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Martinson, M. P. Hans, G.-D. David, and A. M. Elizabeth Readers' choice: Hot papers downloaded in 2006 Cardiovasc Res, March 1, 2007; 73(4): 619 - 622. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hilfiker-Kleiner, U. Landmesser, and H. Drexler Molecular Mechanisms in Heart Failure: Focus on Cardiac Hypertrophy, Inflammation, Angiogenesis, and Apoptosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A56 - A66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. DiMichele, J. T. Doherty, M. Rojas, H. E. Beggs, L. F. Reichardt, C. P. Mack, and J. M. Taylor Myocyte-Restricted Focal Adhesion Kinase Deletion Attenuates Pressure Overload-Induced Hypertrophy Circ. Res., September 15, 2006; 99(6): 636 - 645. [Abstract] [Full Text] [PDF]
|
|